Cancer Companion Guide

Introduction Pancreatic cancer is one of the most aggressive cancers, with complex nutritional and treatment needs. While  surgery, chemotherapy, and targeted therapies remain the standard of care , research increasingly explores  supplemental, metabolic, and repurposed-drug strategies  to support digestion, reduce inflammation, and modulate tumor metabolism. This guide combines  evidence-based supplements, selenium research, metabolic therapy approaches, and the Bigelsen protocol  for an up-to-date, integrative perspective. 1. Pancreatic Enzyme Replacement Therapy (PERT) Pancreatic exocrine insufficiency (PEI) is common in pancreatic cancer, leading to poor digestion, malnutrition, and weight loss. Key Points: PERT helps digest fats, proteins, and carbohydrates . Crucial after surgeries like the Whipple procedure . Prescription options (Creon, Pancreaze) are recommended; over-the-counter enzymes vary in potency. Dosing should be guided by a healthcare professio...

Looking for a Cancer Specialist in USA?  Information is a powerful tool when you or a loved one is facing a critical healthcare decision—especially when selecting a hospital or care team for cancer treatment. This choice can directly impact lives, making it essential to choose wisely. One of the things cancer patients often experience is that everyone around them seems to have advice—drink this, take that, see this therapist, stop eating certain foods, start eating others. It can quickly become overwhelming. For patients, it’s a new and unfamiliar situation, and they often lack the experience to navigate it effectively. The real danger is that patients may try to do too much, picking bits and pieces from different recommendations. A sense of panic can creep in, fueled by the fear of missing out on something that could help. This vulnerability also leaves them at greater risk of falling for unproven or even harmful "miracle cures" promoted by unscrupulous individuals. This is ...

Artificial Intelligence (AI) is rapidly transforming oncology —from early detection and diagnosis to drug discovery, treatment selection, and clinical research. Many cancer experts believe AI will reshape cancer care over the next decade in a similar way that genomics did in the early 2000s. Below are the most important ways AI is changing cancer treatment and oncology research . 1. Earlier Cancer Detection One of the biggest benefits of AI is detecting cancer earlier than traditional methods . AI models can analyze: medical imaging pathology slides blood biomarkers genetic data AI in imaging AI systems can detect subtle patterns in medical scans that radiologists might miss. In some cases, imaging data may be noisy or difficult to interpret due to resolution limits, motion artifacts, or incomplete scan coverage. AI algorithms can analyze these images in real time, identifying anomalies, missing anatomical regions, or areas that require closer review. When potential issues are detected...

Cancer remains a leading cause of morbidity and mortality worldwide, with an increasing incidence of aggressive and treatment-resistant tumors such as triple-negative breast cancer (TNBC), pancreatic adenocarcinoma, and glioblastoma. Despite significant advances in targeted therapies and immunotherapies, many patients continue to face limited effective options, highlighting an urgent need for novel, affordable, and accessible treatment strategies. The high cost of oncology drugs-exceeding $150 billion globally in 2022-and the slow pace of new drug approvals further complicate timely patient access to effective therapies. In this context, drug repurposing-the strategy of identifying new therapeutic uses for existing drugs-has emerged as a promising approach to accelerate cancer treatment development while reducing costs and safety risks. Among repurposed candidates , antiparasitic drugs such as fenbendazole, mebendazole, and ivermectin have attracted considerable attention due to their ...

Cancer treatment outcomes can vary significantly depending on where patients receive care. While many hospitals provide excellent oncology services, some institutions stand out because of their advanced research programs, multidisciplinary care teams, and access to cutting-edge clinical trials . In the United States, several organizations evaluate and rank cancer hospitals based on survival rates, patient safety, physician expertise, and research innovation. Among the most widely cited rankings are those from U.S. News & World Report, which publishes its Best Hospitals for Cancer list annually. Below is an updated guide to the top cancer centers in the United States in 2026 , based largely on these rankings and other reputable evaluations. Top 10 Cancer Centers in the United States 1. University of Texas MD Anderson Cancer Center Location: Houston, Texas MD Anderson has consistently ranked as the #1 cancer hospital in the United States in multiple U.S. News rankings. Why MD Ander...

Cancer treatment has changed dramatically over the past few decades. For much of modern medical history, chemotherapy was the primary systemic therapy used to treat cancer. Today, immunotherapy is transforming the field of oncology by enabling the immune system to recognize and attack cancer cells. Patients newly diagnosed with cancer often face a confusing array of treatment options. Many ask important questions such as: Is immunotherapy better than chemotherapy? What are the risks and benefits of each treatment? Which cancers respond best to immunotherapy? Can these therapies be combined? What happens if immunotherapy fails? Understanding the differences between chemotherapy and immunotherapy can help patients make more informed decisions together with their healthcare providers. This comprehensive guide explains how these treatments work, their effectiveness, side effects, survival outcomes, costs, and emerging innovations in cancer therapy. Credit:  Statista What Is Chemother...

Colorectal cancer — once considered a disease of older adults — is now the number one cause of cancer-related death in Americans under age 50 , according to new research published in the Journal of the American Medical Association (JAMA). This alarming shift marks a major public-health milestone and highlights the urgent need for better awareness, early screening, and research into causes.  A Dramatic Shift in Cancer Mortality Trends Until recently, cancers like lung, breast, and leukemia were the top killers for people under 50. But a new analysis of U.S. cancer mortality data from 1990 through 2023 shows that colorectal cancer (CRC) mortality has increased by about 1.1% per year , even as deaths from most major cancers have declined. By 2023, colorectal cancer had risen from the fifth leading cause of cancer death in younger adults to the first . ( American Hospital Association ) Key Trend Drivers Decreases in death rates for other cancers (lung, breast, leukemia, brain). ...

Abstract Prostate cancer remains one of the most prevalent malignancies among men worldwide, with substantial heterogeneity in risk, progression, and therapeutic response. While advances in androgen receptor–targeted therapies and immunotherapy have improved outcomes in metastatic disease, overall survival gains remain modest for many patients. Concurrently, growing evidence suggests that lifestyle factors, dietary patterns, environmental exposures, and socioeconomic determinants play a critical role in disease risk and post-diagnosis survival. This review synthesizes recent evidence on prostate cancer risk factors and prevention, evaluates contemporary treatment strategies and guideline updates through 2025–2026, summarizes the evolving clinical trial landscape, and critically examines emerging case series involving repurposed antiparasitic agents such as fenbendazole and ivermectin. The convergence of population-level prevention, precision oncology, and real-world patient experimenta...